Dr. Drew W Rasco, MD
Claim this profileSTART South Texas Accelerated Research Therapeutics
About Drew W Rasco, MD
Education:
- Earned an MD from the University of Texas Health Sciences Center, San Antonio, TX, in 2003.
Experience:
- Completed residency in Internal Medicine at Emory University School of Medicine, Atlanta, GA.
- Fellowships in Hematology and Oncology at the University of Texas Southwestern Medical Center, Dallas, TX.
- Board-certified in Hematology and Oncology.
- Associate Director of Clinical Research at South Texas Accelerated Research Therapeutics (START).
- Principal investigator for research leading to FDA approval of treatments, including the combination of lenvatinib and pembrolizumab for endometrial cancer in 2019.
Area of expertise
Cancer
Drew W Rasco, MD has run 12 trials for Cancer. Some of their research focus areas include:
Solid Tumors
Drew W Rasco, MD has run 10 trials for Solid Tumors. Some of their research focus areas include:
Affiliated Hospitals
START South Texas Accelerated Research Therapeutics
South Texas Accelerated Research Therapeutics (START)
Clinical Trials Drew W Rasco, MD is currently running
Immunotherapy
for Pancreatic Cancer
This trial tests a new treatment for pancreatic cancer using a special vaccine, a virus for delivery, and an immune-boosting drug. It aims to help the immune system better fight cancer in patients whose disease has spread, is locally advanced, or has been surgically removed. Vaccine therapy is being tested for many forms of cancer, including pancreatic cancer, with early trials showing safety and some increased survival.
Recruiting
1 award
Phase 1
FX-909
for Bladder Cancer
This trial tests a new tablet called FX-909 for safety and proper dosage in patients with advanced solid tumors, especially advanced urothelial carcinoma. Doctors will closely monitor patients to understand how the drug works and its effects on the body and tumors.
Recruiting
1 award
Phase 1
More about Drew W Rasco, MD
Clinical Trial Related
9 years of experience running clinical trials · Led 22 trials as a Principal Investigator · 8 Active Clinical Trials
Treatments Drew W Rasco, MD has experience with
- Pembrolizumab
- Dostarlimab
- Aldesleukin
- AU-007
- CC-95251
- Cetuximab
Breakdown of trials Drew W Rasco, MD has run
Cancer
Solid Tumors
Pancreatic Cancer
Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Drew W Rasco, MD specialize in?
Drew W Rasco, MD focuses on Cancer and Solid Tumors. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage III.
Is Drew W Rasco, MD currently recruiting for clinical trials?
Yes, Drew W Rasco, MD is currently recruiting for 8 clinical trials in Grand Rapids Michigan. If you're interested in participating, you should apply.
Are there any treatments that Drew W Rasco, MD has studied deeply?
Yes, Drew W Rasco, MD has studied treatments such as Pembrolizumab, Dostarlimab, Aldesleukin.
What is the best way to schedule an appointment with Drew W Rasco, MD?
Apply for one of the trials that Drew W Rasco, MD is conducting.
What is the office address of Drew W Rasco, MD?
The office of Drew W Rasco, MD is located at: START South Texas Accelerated Research Therapeutics, Grand Rapids, Michigan 49503-2563 United States. This is the address for their practice at the START South Texas Accelerated Research Therapeutics.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.